NTT Docomo Ventures has invested in Validic, Inc. to enhance its digital healthcare services through a partnership focused on the 'd Healthcare' application.
Information on the Target
Validic, Inc. is a leading healthcare technology company that specializes in providing digital health solutions. The firm focuses on enabling healthcare systems to integrate and manage patient data through its innovative platform, which connects various health applications, devices, and services.
The company aims to improve health outcomes by facilitating seamless data sharing between patients and healthcare providers. Through its services, Validic seeks to empower individuals to take control of their healthcare journey and enhance the overall patient experience.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Japan
The healthcare technology industry in Japan has been experiencing significant growth in recent years, driven by the increasing need for patient-centered solutions and
Similar Deals
Otsuka Pharmaceutical Co., Ltd. → 4D Molecular Therapeutics
2025
Wontech → SheepMedical
2025
KYORIN Pharmaceutical → BIODOL Therapeutics
2025
日本産業推進機構グループ (NSSK) → 株式会社キート (Kito Co., Ltd.)
2023
Fujimoto Pharmaceutical Corporation → Emcitate
2023
NTT Docomo Ventures
invested in
Validic, Inc.
in 2023
in a Strategic Partnership deal